A Case of Acquired Penetrating Dermatosis

Total Page：16

File Type：pdf, Size：1020Kb

GENETICS AND GENODERMATOSES A CASE OF ACQUIRED PENETRATING DERMATOSIS Ling Li (1) School Of Medicine Of University Of Electronic Science And Technology, Department Of Dermatology,institute Of Dermatology And Venereology, Sichuan Academy Of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China (1) Background: Acquired penetrating dermatosis includes: creeping perforating elastic fiber disease, reactive penetrating collagen disease, perforating folliculitis and Kyrle's disease. This disease is often accompanied by chronic renal failure and one systemic disease at least. Observation: A 69-year-old woman with erythema, plaque, erosion and pain on her left face was admitted to the hospital for 3 years. Three years ago, a bright red patch of nail cap size appeared on her left side face, accompanied by slight pain, itching, and suspicion of Discoid Lupus Erythematosus.Two biopsies of left facial skin lesion suggested that HPV infection of squamous epithelium pseudodermoid hyperplasia and acid-fast staining was negative.The patient were admitted to the ward with DLE and contact dermatitis, Patient suffer from nephrotic syndrome for 30 + years, hypertension for 20 years, hypothyroidism, Hashimoto's thyroiditis for 10 + years, Skin examination: Dark brown-red plaques with obvious infiltrationon on left cheek, hard nodules, epidermis loss, erosion and reddish granulation tissue were observed,beans to coins dark brown patches on the back of the nose, with pigmentation on the edges.The pathological biopsy of facial skin showed that the skin tissues were hyperkeratosis and keratosis, no liquefaction of basal cells and pigment incontinence, hyperplasia of dermal fibers, and infiltration of chronic inflammatory cells around blood vessels. Diagnosis: acquired penetrating dermatosis. 0.1% tacrolimus bid, red light irradiation on facial skin lesions, the patient was discharged from hospital with change for the better. Key message: Acquired penetrating dermatosis nephrotic syndrome for 30 + years, hypertension for 20 years, hypothyroidism, Hashimoto's thyroiditis for 10 + years Powered by TCPDF (www.tcpdf.org).

Copy Link

Recommended publications

Oral Lichen Planus: a Case Report and Review of Literature
Journal of the American Osteopathic College of Dermatology Volume 10, Number 1 SPONSORS: ',/"!,0!4(/,/'9,!"/2!4/29s-%$)#)3 March 2008 34)%&%,,!"/2!4/2)%3s#/,,!'%.%8 www.aocd.org Journal of the American Osteopathic College of Dermatology 2007-2008 Officers President: Jay Gottlieb, DO President Elect: Donald Tillman, DO Journal of the First Vice President: Marc Epstein, DO Second Vice President: Leslie Kramer, DO Third Vice President: Bradley Glick, DO American Secretary-Treasurer: Jere Mammino, DO (2007-2010) Immediate Past President: Bill Way, DO Trustees: James Towry, DO (2006-2008) Osteopathic Mark Kuriata, DO (2007-2010) Karen Neubauer, DO (2006-2008) College of David Grice, DO (2007-2010) Dermatology Sponsors: Global Pathology Laboratory Stiefel Laboratories Editors +BZ4(PUUMJFC %0 '0$00 Medicis 4UBOMFZ&4LPQJU %0 '"0$% CollaGenex +BNFT2%FM3PTTP %0 '"0$% Editorial Review Board 3POBME.JMMFS %0 JAOCD &VHFOF$POUF %0 Founding Sponsor &WBOHFMPT1PVMPT .% A0$%t&*MMJOPJTt,JSLTWJMMF .0 4UFQIFO1VSDFMM %0 t'"9 %BSSFM3JHFM .% wwwBPDEPSg 3PCFSU4DIXBS[F %0 COPYRIGHT AND PERMISSION: written permission must "OESFX)BOMZ .% be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of .JDIBFM4DPUU %0 more than half page, tables or figurFT Permissions are $JOEZ)PGGNBO %0 normally granted contingent upon similar permission from $IBSMFT)VHIFT %0 the author(s), inclusion of acknowledgement of the original source, and a payment of per page, table or figure of #JMM8BZ %0 reproduced matFSJBMPermission fees
[Show full text]
A Report of Kyrle's Disease (Hyperkeratosis Penetrans) in a 43
A Report of Kyrle’s Disease (Hyperkeratosis Penetrans) in a 43-Year-Old Male with End-Stage Renal Disease Ryan Skinner, DO,* Nina Sabzevari, BS,** Daniel Hurd, DO*** *Chief resident, Dermatology Department, LewisGale Hospital Montgomery, Blacksburg, VA **4th-year medical student, Edward Via College of Osteopathic Medicine, Blacksburg, VA ***Program Director, Dermatology Residency Program, LewisGale Hospital Montgomery, Blacksburg, VA Disclosures: None Correspondence: Ryan Skinner, DO; [email protected] Abstract Kyrle’s disease, also known as hyperkeratosis penetrans or hyperkeratosis follicularis et parafollicularis in cutem penetrans, is a rare condition, classified as one of the perforating dermatoses. Clinical presentation is typically numerous red-brown nodules with a scaly crust and central hyperkeratotic plug. Although an identifiable cause has yet to be established, there appears to be a strong relationship with end-stage renal disease and diabetes mellitus. In this report, we present a case of Kyrle’s disease in a 43-year-old male with multiple comorbid medical conditions and provide a review of efficacious treatments. Introduction was first described in 1916 and usually presents The etiology of Kyrle’s disease is unknown, Perforating dermatoses, including Kyrle’s disease as an extensive, painless papular eruption with a and although in some cases it appears to be (or hyperkeratosis follicularis et parafollicularis hyperkeratotic central plug. It most commonly a primary perforating skin disorder, in others involves the lower extremities but can also it occurs secondary to chronic kidney disease, in cutem penetrans), perforating folliculitis, 3 elastosis perforans serpiginosa, and reactive involve the upper extremities and trunk. There liver disease, congestive heart failure or diabetes is no involvement of the acral surfaces or mucous mellitus.4 Treatment is focused on managing perforating collagenosis, are disorders of 3 transepithelial destruction of dermal structures, membranes.
[Show full text]
Elastosis Perforans Serpiginosa: a D-Penicillamine Induced Dermatoses in a Patient with Wilson’S Disease
Article / Clinical Case Report Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease Swagatika Samala , Mukund Sablea How to cite: Samal S, Sable M. Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease. Autops Case Rep [Internet]. 2020 Apr-Jun;10(2):e2020167. https://doi.org/10.4322/acr.2020.167 ABSTRACT Long term use of D-penicillamine for Wilson’s disease can be associated with many adverse reactions and systemic side effects. We report the case of a 28-year-old male patient diagnosed with Wilson’s disease presenting with a serpiginous raised violaceous skin lesion in the anterior aspect of the neck over the last six months and two small papules with central umbilication during the last month. Histopathological examination of skin lesions demonstrated transepidermal perforating channel, and the Verhoeff’s-van Gieson stain showed marked increase number of irregular serrated elastic fibers suggesting the diagnosis of D- penicillamine induced elastosis perforans serpiginosa. Keywords Skin Diseases; Biopsy; Elastic tissue. INTRODUCTION CASE REPORT D-penicillamine (DPA) therapy is the mainstay A 28-year-male diagnosed with WD on oral DPA of chelation therapy for patients of Wilson’s therapy (250 mg thrice daily) for the last 18 years disease (WD). Various systemic adverse effects, presented with serpiginous raised violaceous skin including many dermatological manifestations, lesions in the anterior aspect of neck over the last may be observed with prolonged use of this drug. six months and two small papules with central The dermatological side effects of DPA can be of three umbilication for one month (Figure 1).
[Show full text]
Acquired Perforating Dermatosis
Dermatology Online Journal UC Davis Peer Reviewed Title: Acquired perforating dermatosis: a clinical and dermatoscopic correlation Journal Issue: Dermatology Online Journal, 19(7) Author: Ramirez-Fort, Marigdalia K., Tufts Medical Center Khan, Farhan, Center for Clinical Studies Rosendahl, Cliff O., The University of Queensland Mercer, Stephen E., The Mount Sinai School of Medicine Shim-Chang, Helen, The Mount Sinai School of Medicine Levitt, Jacob O., The Mount Sinai School of Medicine Publication Date: 2013 Publication Info: Dermatology Online Journal Permalink: http://escholarship.org/uc/item/7q40n20h Keywords: Dermatosis, Medicine Local Identifier: doj_18958 Abstract: Acquired Perforating Dermatosis (APD) is a perforating disease characterized by transepidermal elimination of dermal material [1,2]. This disease usually develops in adulthood. APD has been reported to occur in association with various diseases, but is most commonly associated with dialysis-dependent chronic renal failure (CRF) or diabetes mellitus (DM) [1,2,3,4]. Morton et al found that APD occurs in up to 10% of patients undergoing hemodialysis [5]. Additionally, Saray et al found that sixteen of twenty-two cases with APD were associated with CRF [3]. Copyright Information: eScholarship provides open access, scholarly publishing services to the University of California and delivers a dynamic research platform to scholars worldwide. Copyright 2013 by the article author(s). This work is made available under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs3.0 license, http:// creativecommons.org/licenses/by-nc-nd/3.0/ eScholarship provides open access, scholarly publishing services to the University of California and delivers a dynamic research platform to scholars worldwide. Volume 19 Number 7 July 2013 Case Report Acquired perforating dermatosis: a clinical and dermatoscopic correlation Marigdalia K.
[Show full text]
Elastosis Perforans Serpiginosa Secondary to D-Penicillamine Therapy with Coexisting Cutis Laxa
Elastosis Perforans Serpiginosa Secondary to D-Penicillamine Therapy With Coexisting Cutis Laxa Les B. Rosen, MD; Matthew Muellenhoff, DO; Thi T. Tran, DO; Michelle Muhart, MD Elastosis perforans serpiginosa (EPS) is a rare The patient presented to dermatology with a new complication of D-penicillamine therapy. EPS has onset eruption involving the back, axillae, chest, been reported in patients with Wilson disease, upper arms, and legs bilaterally. She stated this erup- cystinuria, and rheumatoid arthritis after many tion was sensitive to touch and contact with cloth- years of high-dose therapy. We report a case of ing. Findings from a physical examination showed D-penicillamine–induced EPS with coexisting loose hyperextensible skin on the trunk and extrem- acquired cutis laxa in a patient with cystinuria. ities with overlying grouped keratotic erythematous Although both EPS and acquired cutis laxa can papules arranged in a serpiginous pattern (Figure 2). be associated with D-penicillamine therapy, few Results of a 3-mm punch biopsy revealed short, cases have been reported with overlapping clin- thick, eosinophilic fibers with transepidermal elimi- ical presentations, and previously only in nation of elastin (Figure 3). The Verhoeff-van patients with Wilson disease. We review the Gieson stain highlighted elastic fibers with nodular characteristic clinical and histologic features of protrusions, giving a “zipperlike” pattern throughout EPS and discuss the potential dermatologic the dermis (Figure 4). Foreign body–type giant cell manifestations of D-penicillamine therapy. reaction to the elastic fiber was present. Cutis. 2005;76:49-53. The patient’s history and clinical and histologic find- ings supported the final diagnosis of elastosis perforans serpiginosa (EPS) secondary to D-penicillamine Case Report therapy with coexisting acquired cutis laxa.
[Show full text]
Computer Diagnosis of Skin Disease
COMPUTERS IN FAMILY PRACTICE Computer Diagnosis of Skin Disease Brian Potter, MD, and Salve G. Ronan, MD Michigan City, Indiana, and Chicago, Illinois A transferable computer program for the differential diagnosis of diseases of the skin, CLINDERM, has been produced for use by physicians on standard IBM and compat ible personal microcomputers. This program lists the differential diagnosis and defini tive diagnosis of any presented disease of the skin, except single tumors. The physi cian operator indicates the distribution and detailed description of lesions, which the interactive system integrates with a comprehensive knowledge base. The computer diagnosis in 129 cases was compared with independent interpreta tion of the same information by an academic dermatologist. Results were synony mous in 66.7% of all diseases and similar in an additional 4.7%. A common differen tial diagnosis was obtained in 24%, for a 95.3% rate of synonymous, similar, or common differential diagnoses. Diagnosis was different in 3.9% and description was inadequate for diagnosis in 0.8%. The variation in diagnosis showed that some descriptive terms are prejudicial of certain diagnoses; that diagnostic terms are not all completely standardized; that some diagnoses are variants of another disease; and that drug-induced eruptions simulate many other diseases. A skin disease can usually be diagnosed by specific description. Most lesions that are not diagnostic from inspection are nodular. A computer can be programmed to list diagnoses according to morphologic description J Fam Pract 1990; 30:201-210. functional, transferable computer software system examination may, however, be excessively complex. Ob Afor the differential diagnosis of diseases of the skin, jectivity is improved by recording specific features ac called CLINDERM,* has been produced for use by phy cording to sets of standardized criteria.
[Show full text]
Clinical Dermatology
CLINICAL DERMATOLOGY A Manual of Differential Diagnosis Third Edition By Stanferd L. Kusch, MD Compliments of: www.taropharma.com Copyright © 1979 (original edition) by Stanferd L. Kusch, MD Second Edition 1987 Third Edition 2003 All rights reserved. No part of the contents of this book may be reproduced or transmitted in any form or by any means, including photocopying, without the written permission of the copyright owner. NOTICE Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The author and the publisher of this work have checked with sources believed to be reliable in their efforts to pro- vide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the author nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or com- plete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information here- in with other sources. For example and in particular, readers are advised to check the product information sheet included in the pack- age of each drug they plan to administer to be certain that the infor- mation contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
[Show full text]
University of Chicago, December 2019
Chicago Dermatological Society Monthly Educational Conference Program Information CME Certification and Case Presentations Wednesday, December 4, 2019 Gleacher Center – Chicago, IL Conference Host: Section of Dermatology University of Chicago Hospitals Chicago, Illinois Program Host: University of Chicago Wednesday, December 4, 2019 Gleacher Center, Chicago 8:00 a.m. Registration & Continental Breakfast with Exhibitors All conference activities take place on the 6th Floor 8:30 a.m. - 10:30 a.m. Clinical Rounds Slide viewing and posters 9:00 a.m. - 10:00 a.m. Morning Lecture "Updates in Hair Disorders" Amy McMichael, MD 10:00 a.m. - 10:30 a.m. Break and Visit with Exhibitors 10:30 a.m. - 12:15 p.m. Resident Case Presentations & Discussion; MOC Self-Assessment Questions 12:15 p.m. - 12:45 p.m. Box Lunches & visit with exhibitors 12:55 p.m. - 1:00 p.m. CDS Business Meeting 1:00 p.m. - 2:00 p.m. General Session LORINCZ LECTURE – “Skin of Color Updates” Amy McMichael, MD 2:00 p.m. Meeting adjourns PLEASE NOTE THE FOLLOWING POLICY ADOPTED BY THE CDS TO COMPLY WITH HIPAA PRIVACY RULES: Taking personal photos of posters or other displays, of images included in general session lectures or presentations, and of live patients at CDS conferences is strictly prohibited. Making audio recordings of any session at a CDS conference also is prohibited. Mark the Date! Next CDS meeting will be on Wednesday, April 15th at the Gleacher Center downtown. Watch for details on the CDS website: www.ChicagoDerm.org Save time and money – consider registering online! Guest Speaker AMY MCMICHAEL, MD Professor of Dermatology and Chair, Department of Dermatology Wake Forest School of Medicine Winston-Salem, NC Dr.
[Show full text]
Elastosis Perforans Serpiginosa: a D-Penicillamine Induced Dermatoses in a Patient with Wilson’S Disease
Article / Clinical Case Report Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease Swagatika Samala , Mukund Sablea How to cite: Samal S, Sable M. Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease. Autops Case Rep [Internet]. 2020; 10(2):e2020167. https://doi.org/10.4322/acr.2020.167 ABSTRACT Long term use of D-penicillamine for Wilson’s disease can be associated with many adverse reactions and systemic side effects. We report the case of a 28-year-old male patient diagnosed with Wilson’s disease presenting with a serpiginous raised violaceous skin lesion in the anterior aspect of the neck over the last six months and two small papules with central umbilication during the last month. Histopathological examination of skin lesions demonstrated transepidermal perforating channel, and the Verhoeff’s-van Gieson stain showed marked increase number of irregular serrated elastic fibers suggesting the diagnosis of D- penicillamine induced elastosis perforans serpiginosa. Keywords Skin Diseases; Biopsy; Elastic tissue. INTRODUCTION CASE REPORT D-penicillamine (DPA) therapy is the mainstay A 28-year-male diagnosed with WD on oral DPA of chelation therapy for patients of Wilson’s therapy (250 mg thrice daily) for the last 18 years disease (WD). Various systemic adverse effects, presented with serpiginous raised violaceous skin including many dermatological manifestations, lesions in the anterior aspect of neck over the last may be observed with prolonged use of this drug. six months and two small papules with central The dermatological side effects of DPA can be of three umbilication for one month (Figure 1).
[Show full text]
PDF Download Scar Tissue Kindle
SCAR TISSUE PDF, EPUB, EBOOK Anthony Kiedis | 480 pages | 03 Nov 2005 | Little, Brown Book Group | 9780751535662 | English | London, United Kingdom Scar Tissue PDF Book Scars result from the biological process of wound repair in the skin, as well as in other organs and tissues of the body. For some people, scar tissue may cause pain, tightness, itching, or difficulty moving. Folder Name. Scars can be unsightly and difficult to remove. When a person first sustains an injury, they usually experience pain due to inflammation and damage to the skin. Bleomycin is a treatment that doctors use in cancer treatments. Initially, the scarring may look minimal, but over 4—6 weeks, the scar may get bigger or become raised, firm, and thick. Lichen sclerosus Anetoderma Schweninger—Buzzi anetoderma Jadassohn—Pellizzari anetoderma Atrophoderma of Pasini and Pierini Acrodermatitis chronica atrophicans Semicircular lipoatrophy Follicular atrophoderma Linear atrophoderma of Moulin. It is thought to be effective despite a lack of clinical trials, but only used in extreme cases due to the perceived risk of long-term side effects. How to get rid of burn scars. You can also prevent keloids by using pressure treatment, silicone gel. How you scar depends on many factors: the depth and size of your wound, your age, heredity, even your sex and ethnicity. Lay summary. This is composed of the same main protein collagen as normal skin, but with differences in details of composition. Retrieved 23 May Typically, people will receive radiotherapy after having a keloid removed to reduce the formation of another keloid. People can apply dressings onto the scar tissue that apply pressure.
[Show full text]
Download Full Article
International Journal of Dermatology, Venereology and Leprosy Sciences. 2020; 3(2): 27-34 E-ISSN: 2664-942X P-ISSN: 2664-9411 www.dermatologypaper.com/ Spectrum of dermatological manifestations in systemic Derma 2020; 3(2): 27-34 Received: 06-07-2020 diseases Accepted: 16-08-2020 Dr. Munnaluri Mohan Rao Dr. Munnaluri Mohan Rao, Dr. Kotha Raghupathi Reddy and Dr. Associate Professor, Chittla Sravan Department of DVL, Great Eastern Medical School and Hospital, Ragolu Srikakulam, DOI: https://doi.org/10.33545/26649411.2020.v3.i2a.42 Andhra Pradesh, India Abstract Dr. Kotha Raghupathi Reddy Aims: It is a well-known fact that the skin is referred to as the mirror or window to the body. The Associate Professor, present study was undertaken with the objectives of knowing the spectrum of dermatological Department of DVL, Gandhi manifestations in systemic diseases. Medical College, Materials and Methods: A total of 100 patients with systemic illness presenting with dermatological Secunderabad, Telangana, India manifestations were included in the study. Relevant investigations for the diagnosis of systemic illness and dermatological disorders were carried out. Dr. Chittla Sravan Results: Majority (51%) of the cases belonged to the age group 41-60 years with 54% of the cases Assistant Professor, having diabetes mellitus, renal and hepatobiliary disorders. Among the 100 cases, the underlying Department of DVL, MNR systemic disorder was detected in 21 because of the dermatological manifestations. Various dermatoses Medical College and Hospital, observed in patients of diabetes mellitus were xerosis, pruritus, bacterial infections, diabetic bullae, Sangareddy, Telangana, India prurigo, fungal infections and diabetic dermopathy. Renal disorders presented with xerosis, acquired ichthyosis, pruritus and pigmentation of the face.
[Show full text]
Delineating the Perforating Dermatoses: Case Reports and a Review of the Literature
Delineating the Perforating Dermatoses: Case Reports and a Review of the Literature Richard Limbert, DO,* Rachel White, BA,** Richard Miller, DO, FAOCD*** *Dermatology Resident, 3rd year, Nova Southeastern / Largo Medical Center, Largo, FL **Medical Student, 4th year, Philadelphia College of Osteopathic Medicine, Philadelphia, PA ***Program Director, Dermatology Residency, Nova Southeastern / Largo Medical Center, Largo, FL Abstract Perforating dermatoses (PD) are a rare group of papulonodular skin diseases with a distinct central keratotic core representing the transepidermal elimination of an altered dermal substance. Diagnosis is established via biopsy and histopathologic evaluation. The primary PD are best categorized into four groups: reactive perforating collagenosis (RPC), acquired perforating dermatosis (APD), elastosis perforans serpiginosa (EPS), and perforating calcific elastosis (PCE). The primary PD can be differentiated based on the perforating substance, the distribution of the lesions, and their unique associations. Diagnosis of a PD should prompt screening for underlying systemic disease. Treatment of the PD is often difficult, but numerous reports have shown success. Here we present our case reports and a thorough literature review incorporating all identified case reports and studies found on PubMed as of July 2015. Introduction follicular structures. Special stains may be used to Perforating dermatoses (PD) represent a rare help identify the perforating substance. group of papulonodular skin diseases with a The precise pathogenesis of the PD is unknown. It distinct central keratotic core. The core represents is postulated that the primary PD may be due to the transepidermal elimination of an altered abnormal dermal substances, whether genetically 1 dermal substance. Diagnosis is established altered or acquired. Other theories question via biopsy and histopathologic evaluation.
[Show full text]